Search

everythinglearnresearchcommunity

for

Search:↓

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Many survivors of critical illness, especially those with sepsis, experience hair loss.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

The triple rotation scalp flap technique successfully reconstructed a man's scalp with natural-looking hair growth and minimal scarring.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Ingesting minoxidil can cause serious heart problems and requires urgent medical treatment.

About 61% of women who had COVID-19 experienced hair loss afterward.

Low testosterone levels may lead to more severe COVID-19 outcomes.

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

Certain eye surgery complications can be managed effectively, especially in patients who have used specific prostate medications.

Frontalis suspension surgery using autologous fascia lata is effective for treating unilateral congenital ptosis with poor levator function.

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

Itraconazole is potentially effective for treating invasive aspergillosis, but more research is needed.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Diuretics can cause serious side effects and should be used carefully.

New therapies for burn wounds show promise in reducing pain, infection risk, and improving healing and physical outcomes.

A woman with severe hair loss due to systemic sclerosis regrew her hair in 4 months using a combination of treatments.